Antonieta Salud-Salvia
Lleida, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 01, 2024
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 25, 2022
Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 21, 2020
Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study.
Journal: ESMO open
Published: October 26, 2020
Selection of neoadjuvant treatment based on the 21-GENE test results in luminal breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: June 17, 2020
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients.
Journal: Neoplasia (New York, N.Y.)
Published: April 11, 2018
Continued erlotinib maintenance and salvage radiation for solitary areas of disease progression: a useful strategy in selected non-small cell lung cancers?
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: September 25, 2012
Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 11, 2012
Human papillomavirus in non-small-cell lung cancer: the impact of EGFR mutations and the response to erlotinib.
Journal: Archivos de bronconeumologia
Published: January 01, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026